Johannes R Kratz

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi Genomic prognostic models in early-stage lung cancer
    Johannes R Kratz
    Department of Surgery, University of California San Francisco Cancer Center, CA 94143 0128, USA
    Clin Lung Cancer 10:151-7. 2009
  2. pmc Cancer stem cells in lung tumorigenesis
    Johannes R Kratz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Ann Thorac Surg 89:S2090-5. 2010
  3. doi Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer
    Johannes R Kratz
    Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA
    Diagn Mol Pathol 22:65-9. 2013
  4. pmc The role of stem cells in airway repair: implications for the origins of lung cancer
    Michael S Mulvihill
    Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA
    Chin J Cancer 32:71-4. 2013
  5. pmc Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
    Kush M Parmar
    Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Invest 116:49-58. 2006

Collaborators

  • David M Jablons
  • Biao He
  • Mark R Segal
  • Michael S Mulvihill
  • Kush M Parmar
  • Patrick Pham
  • Guohao Dai
  • Zhiyong Lin
  • H Benjamin Larman
  • Sripriya N Moorthy
  • Michael A Gimbrone
  • Guillermo Garcia-Cardena
  • Mukesh K Jain
  • Eric T Wang
  • Yuzhi Zhang

Detail Information

Publications5

  1. doi Genomic prognostic models in early-stage lung cancer
    Johannes R Kratz
    Department of Surgery, University of California San Francisco Cancer Center, CA 94143 0128, USA
    Clin Lung Cancer 10:151-7. 2009
    ..An effort to develop a robust genomic model for use in the clinical setting should be prompted by encouraging results obtained by the use of a quantitative PCR-based genomic signature in the field of breast oncology...
  2. pmc Cancer stem cells in lung tumorigenesis
    Johannes R Kratz
    Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
    Ann Thorac Surg 89:S2090-5. 2010
    ..Continued research in the field of lung cancer stem cell biology is vital, as ongoing efforts promise to yield new prognostic and therapeutic targets...
  3. doi Analytical validation of a practical molecular assay prognostic of survival in nonsquamous non-small cell lung cancer
    Johannes R Kratz
    Thoracic Oncology Program, Department of Surgery, University of California, San Francisco, San Francisco, CA, USA
    Diagn Mol Pathol 22:65-9. 2013
    ....
  4. pmc The role of stem cells in airway repair: implications for the origins of lung cancer
    Michael S Mulvihill
    Thoracic Oncology Program, Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA
    Chin J Cancer 32:71-4. 2013
    ..The implications of a stem cell origin of lung cancer are reviewed, and the importance of ongoing research to identify novel therapeutic and prognostic targets is reiterated...
  5. pmc Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2
    Kush M Parmar
    Center for Excellence in Vascular Biology, Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA
    J Clin Invest 116:49-58. 2006
    ..KLF2 therefore serves as a mechano-activated transcription factor important in the integration of multiple endothelial functions associated with regions of the arterial vasculature that are relatively resistant to atherogenesis...